Stock Details
BDX is Becton, Dickinson and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 244.50$. Average daily volumn in 3 months 1.09M. Market cap 68.87B



Stock symbol : BDX. Exchange : NYSE. Currency : USD
Lastest price : 240.11$. Total volume : 169.61k. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

Becton, Dickinson and Company (BDX)
Last Price
240.11$
Change
1.62
Volume
169.61k

Previous Close238.49
Open239.54
Day Range238.20-240.27
Bid239.33 x 800
Ask239.37 x 800
Volume169.61k
Average Volume1.09M
Market Cap68.87B
Beta0.56
52 Week Range215.90-277.29
Trailing P/E46.35
Foward P/E17.63
Dividend (Yield %)1.55%
Ex-Dividend Date2023-03-09



Financial Details


According to Becton, Dickinson and Company's financial reports the company's revenue in 2022 were 18.87B an decrease(-5.26%) over the years 2021 revenue that were of 19.13B. In 2022 the company's total earnings were 1.78B while total earnings in 2021 were 2.09B(-50%).


Loading ...



Organization

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors an... d extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Market Cap:
68.87B
Revenue:
18.87B
Total Assets:
52.93B
Total Cash:
1.01B


News about "Becton, Dickinson and Company"

Becton, Dickinson and Company (NYSE:BDX) Goes Ex-Dividend Soon

Source from : Yahoo Finance - 15 days ago

Readers hoping to buy Becton, Dickinson and Company (NYSE:BDX) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is usually ...See details»


Becton, Dickinson and Company: Reaffirming BUY but lowering target to $280

Source from : Yahoo Finance - 7 days ago

Headquartered in Franklin Lakes, New Jersey, BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions ...See details»


becton-dickinson-co-stock-rises-wednesday-outperforms-market-image

Becton Dickinson & Co. stock rises Wednesday, outperforms market

Source from : MarketWatch - 6 days ago

Shares of Becton Dickinson & Co. inched 0.68% higher to $234.48 Wednesday, on what proved to be an all-around dismal trading session for the stock ...See details»


Becton Dickinson and Co

Source from : Reuters - 2 years ago

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment ...See details»


Becton, Dickinson and Company

Source from : Fortune - 1 month ago

© 2023 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...See details»


Becton Dickinson & Co. Dep. Pfd. (Rep. 1/20th Pfd. Series B)

Source from : Wall Street Journal - 4 days ago

Thomas E. Polen Chairman, President & Chief Executive Officer Advanced Medical Technology Association, Hackensack Meridian Health Foundation, Inc., The Center For Discovery & Innovation, Becton ...See details»


Becton, Dickinson and Company (BDX) Presents at the 43rd Annual Cowen Healthcare Conference - Slideshow

Source from : Seeking Alpha - 11 days ago

Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site ...See details»


Becton, Dickinson and Company Common Stock (BDX)

Source from : Nasdaq - 2 month ago

Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common ...See details»


Becton Dickinson and Company (BDX) Shares Down Despite Recent Market Volatility

Source from : newsheater - 13 days ago

Becton Dickinson and Company (NYSE: BDX)’s stock price has decreased by -0.04 compared to its previous closing price of 236.22. However, the company has experienced a 0.67% gain in its stock price ...See details»


Becton Dickinson & Co. stock rises Tuesday, still underperforms market

Source from : MarketWatch - 7 days ago

Shares of Becton Dickinson & Co. BDX inched 0.65% higher to $232.89 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1. ...See details»


Client Profile: Becton, Dickinson & Co

Source from : OpenSecrets.org - 6 month ago

A special interest's lobbying activity may go up or down over time, depending on how much attention the federal government is giving their issues. Particularly active clients often retain multiple ...See details»


Becton Dickinson: Fiscal Q1 Earnings Snapshot

Source from : The Register Citizen - 1 month ago

FRANKLIN LAKES, N.J. (AP) _ Becton Dickinson and Co. (BDX) on Thursday reported fiscal first-quarter net income of $509 million. On a per-share basis, the Franklin Lakes, New Jersey-based company ...See details»


Becton, Dickinson And Co. To Buy Parata Systems In $1.525 Bln All-cash Deal

Source from : Finanznachrichten - 25 days ago

WASHINGTON (dpa-AFX) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Monday a definitive agreement for BD to acquire Parata Systems, an innovative provider of pharmacy ...See details»


Becton, Dickinson and Company

Source from : Fortune - 3 years ago

© 2023 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...See details»